SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MGI Pharma MOGN New patents, anti cancer
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
1826 45 0 MOGN
Emcee:  Mark Oliver Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
176 Although not "Salagen" proper, I thought that this abstract might be scaram(o)uche-9/12/1997
175 Rick: More on Sjogrens... The following estimates the number of people with SjJOSEPH VON MEISTER-9/12/1997
174 Rick: Chiron ordered a lot of Salagen to fill the pipe in Europe in MGI's fJOSEPH VON MEISTER-9/12/1997
173 David: No. Yes. ;-) But, under conditions where MG 114 is that exciting, thscaram(o)uche-9/12/1997
172 Richard: We share an interest in AGPH. I bought it at 9 (4 1/2, split adjustscaram(o)uche-9/12/1997
171 Rick Boy, I love this kind of talk. $30 milion, $100 million no way would I tseminole-9/12/1997
170 Rick Do you really know enough about MGI 114 to say Blitzer made his first misDavid Cathcart-9/12/1997
169 30M, 15% *and* full development costs would be a very good deal. I imagine, buscaram(o)uche-9/12/1997
168 MZ >> Can you elaborate little bit on this? [Third sign of MGI 114 efficDavid Cathcart-9/12/1997
167 Rick Your response to the Bristol-Myers Squibb issue surprises me. You seem tDavid Cathcart-9/12/1997
166 I'd take $30 million, 15% royalties, all developmental costs borne by BMS. scaram(o)uche-9/12/1997
165 Henry is the primary SI and m.i.s proponent of Ligand, Dr. Niman. He posts ratscaram(o)uche-9/12/1997
164 To all: Glad that optimism returned to MGI board. David: >> Are you awMiljenko Zuanic-9/11/1997
163 Joseph: MGI Pharma is a real company with real scientists, real-world issues ascaram(o)uche-9/11/1997
162 Richard, MOGN did exhibit some resistance in trying to push through $5 today, David Cathcart-9/11/1997
161 Rick I'm not in your league when it comes to analyzing companies. There..David Cathcart-9/11/1997
160 SALAGEN'S MARKET POTENTIAL IS 1 IN 1,250 WOMEN FOR PRIMARY SJOGRENS; IN CAJOSEPH VON MEISTER-9/11/1997
159 David I think $5/share will provide some resistance. I believe many investorsseminole-9/11/1997
158 MGI FANS I found this summary of insider/institutional ownership on Point Castseminole-9/11/1997
157 Geeeeze, they've got the bid/ask set at a spread of 1/32. We're testinscaram(o)uche-9/11/1997
156 I'm going to divide up my answers to your post David, waiting for the coffescaram(o)uche-9/11/1997
155 Rick, I don't think 5 will offer much price resistance. Virtually all of David Cathcart-9/11/1997
154 Jason: Yeah, I almost choked on it as I was typing. Goes against the grain. scaram(o)uche-9/10/1997
153 Richard, We have been waiting a long time for days like the last two. Your SeDavid Cathcart-9/10/1997
152 Rick Here we go. richardseminole-9/10/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News